Zimmer Biomet Holdings, Inc. (ZBH) compounding analysis
Full-size annual and quarterly year-over-year growth charts for revenue, EPS, operating cash flow, EBITDA, and free cash flow against the 15%, 20%, and 30% bars over 3-, 5-, and 10-year windows, with each metric's valuation multiple vs its own history.
Revenue · 5YDoes not currently clear the 15%+, 20%+, or 30%+ revenue bars over 5Y.
- Score
- 19/100
- 5Y CAGR
- 6.1%
- Median YoY
- 4.2%
- YoY volatility
- σ 11.0pp· uneven
- Quarters ≥ 20%
- 1 of 20
- Negative quarters
- 4
- Valuation vs own 5Y history
- P/S 2.0x · 5Y median 3.2x · 7th percentile
How this score is computed
- Quarters at or above 20%: 1 of 20 → 2 of 40 pts
- Steadiness (typical swing 11.0pp) → 17.1 of 25 pts
- Pace (median 4.2% YoY) → 0 of 20 pts
- Latest quarter (9.3% YoY) → 0 of 15 pts
- Score: 19 of 100
Annual revenue · last 11 fiscal years
Quarterly YoY revenue growth vs the 20% line · 5Y
P/S multiple vs its 5Y median · context only
Across metrics · 5Y
| Metric | 5Y CAGR | Median YoY | YoY σ | Qtrs ≥ 20% | Neg. qtrs |
|---|---|---|---|---|---|
| RevenueRevenue | 6.1% | 4.2% | 11.0pp | 1 of 20 | 4 |
| EPSEPS | — | 1.3% | 389.1pp | 5 of 16 | 8 |
| Op cash flowOperating cash flow | 7.1% | 0.4% | 40.3pp | 3 of 20 | 10 |
| EBITDAEBITDA | 20.1% | 4.6% | 109.0pp | 3 of 20 | 8 |
| FCFFree cash flow | 6.2% | -0.1% | 64.6pp | 7 of 20 | 10 |
Reported figures over 5Y: annual-series CAGR, median and standard deviation (σ, percentage points) of quarterly year-over-year growth, quarters at or above 20%, and quarters with negative YoY. “—” means the window needs more comparable data.
Scores, qualification bars, and the 0–100 consistency methodology are documented on the compounders list page →
See also: ZBH on the compounders surface · All compounders, ranked
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ivan Tornos